The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3212-3220

  Smyth, Lesley Ann ^a   Harker, Nicola ^b   Turnbull, Wayne ^a   El Doueik, Haytham ^a   Klavinskis, Linda ^a   Kioussis, Dimitris ^b   Lombardi, Giovanna ^a   Lechler, Robert ^a,c  

^a GUY S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8ALPHA ANTIGEN; DOUBLE STRANDED RNA; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; OVALBUMIN[257-264]; PEPTIDE; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; OVALBUMIN (257 64), MOUSE; OVALBUMIN (257-64), MOUSE; PEPTIDE FRAGMENT;

ADENOVIRUS; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CROSS LINKING; CROSS PRESENTATION; DENDRITIC CELL; EPITHELIUM CELL; EX VIVO STUDY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS RECOMBINANT; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CROSS-PRIMING; DENDRITIC CELLS; EPITHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; OVALBUMIN; PEPTIDE FRAGMENTS; PEPTIDES; SPLEEN;

EID: 51549111448     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3212     Document Type: Article

References (49)

1. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172: 1996-2000.
2. Norbury, C. C. 2003. Cross priming or direct priming: is that really the question? Curr. Opin. Immunol. 15: 82-88.
3. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3: 265-271.
4. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1286.
5. Zinkernagel, R. M. 2002. On cross-priming of MHC class I-specific CTL: rule or exception? Eur. J. Immunol. 32: 2385-2392.
6. + T cells after viral stimulation. PLoS ONE 3: e1691.
7. Masson, F., A. M. Mount, N. S. Wilson, and G. T. Belz. 2008. Dendritic cells: driving the differentiation programme of T cells in viral infections. Immunol. Cell Biol. 86: 333-342. (Pubitemid 351667992)
8. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation in viral immunity and self tolerance. Nat. Rev. Immunol. 1: 126-134. (Pubitemid 33741966)
9. Hertel, L., V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski. 2003. Susceptibility of immature and mature langerhans cell-type dendritic cells to infection an immunomodulation by human cytomegalovirus. J. Virol. 77: 7563-7574. (Pubitemid 36734526)
10. Moutaftsi, M., A. M. Mehl, L. K. Borysiewicz, and Z. Tabi. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99: 2913-2921. (Pubitemid 34525381)
11. Sigal, L. J., and K. L. Rock. 2000. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192: 1143-1150.
12. Sigal, L. J., S. Crotty, R. Andino, and K. L. Rock. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80. (Pubitemid 29124471)
13. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1695.
14. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. USA 103: 10729-10734.
15. + dendritic cells. J. Immunol. 166: 5327-5330.
16. Allen, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Vilandangos, Y. Zhan, A. M. Lew, K. Shortman, W. A. Heath, and F. A. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
17. + dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc. Natl. Acad. Sci. USA 105: 3029-3034.
18. Datta, S. P., V. Redecke, K. R. Prilliman, K. Takabayashi, M. Corr, T. Tallant, J. DiDonato, R. Dziarski, S. Akira, S. P. Schoenberger, and E. Raz. 2003. A sunset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170: 4102-4110.
19. Huang, J., T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus. 2005. Nitric oxide sensitzes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation. Cancer Res. 65: 8461-8470. (Pubitemid 41330614)
20. Herrera, O. B., D. Golshayan, R. Tibbott, F. Salcido Ochoa, M. J. James, F. M. Marelli-Berg, and R. I. Lechler. 2004. A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173: 4828-4837. (Pubitemid 39387763)
21. Dolan, B. P., K. D. Gibbs, Jr., and S. Ostrand-Rosenberg. 2006. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J. Immunol. 176: 1447-1455.
22. + T cells. J. Immunol. 177: 6018-6024.
23. Game, D. S., N. J. Rogers, and R. I. Lechler. 2005. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am. J. Transplant. 5: 1614-1625.
24. Tanaka, Y., O. Williams, R. Tarazona, A. Wack, T. Norton, and D. Kioussis. 1997. In vitro positive selection of αβ TCR transgenic thymocytes by a conditionally immortalised cortical epithelial clone. Int. Immunol. 9: 381-393. (Pubitemid 27113263)
25. Gil-Torregrosa, B. C., A. M. Lennon-Dumenil, B. Kessler, P. Guermonprez, H. L. Ploegh, D. Fruci, P. Van Endert, and S. Amigorena. 2004. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34: 398-407. (Pubitemid 39255950)
26. Herrera, O. B., S. Brett, and R. I. Lechler. 2002. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vector leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design. Vaccine 21: 231-242.
27. Cheng, C., J. C. D. Gall, W.-P. Kong, R. L. Sheet, P. L. Gomez, C. R. King, and G. J. Nabel. 2007. Mechanism of Ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLOS Patholog. 3: e25.
28. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localisation, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726. (Pubitemid 27305734)
29. + dendritic cells is attributable to their ability to internalize dead cells. Immunology 107: 183-189.
30. Smyth, L. A., B. Afzali, J. Tsang, G. Lombardi, and R. I. Lechler. 2007. Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am. J. Transplant. 7: 1-8.
31. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopouou, Y.-T. Azuma, R. A. Flavell, P. Lijestrom, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-892.
32. Reis e Sousa, C., and R. N. Germain. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182: 841-851.
33. Stoitzner, P., C. H. Tripp, A. Eberhart, K. M. Price, J. Y. Jung, L. Bursch, F. Ronchese, and N. Romani. 2006. Langerhan cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. USA 103: 7783-7788. (Pubitemid 43752858)
34. Klotman, M. E., and T. L. Chang. 2006. Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6: 447-456.
35. Proud, D., S. P. Sanders, and S. Wiehler. 2004. Human rhinovirus infection induces airway epithelial cells production of human b- defensins. J. Immunol. 172: 4637-4645.
36. Biragyn, A., P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov, O. Chertov, A. K. Shirakawa, J. M. Farber, D. M. Segal, J. J. Oppenheim, and L. W. Kwak. 2002. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029. (Pubitemid 35247310)
37. + T cell cross-priming in vivo. Immunity 24: 191-201.
38. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
39. Chung, Y., J.-H. Chang, B.-S. Kin, J.-M. Lee, H.-Y. Kim, and C.-Y. Kang. 2007. Anatomic location defines antigen presentation by dendritic cells to T cell in response to intravenous soluble antigen. Eur. J. Immunol. 37: 1453-1462. (Pubitemid 46939482)
40. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. Steptoe, K. D. Shortman, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7: 166-172.
41. + T cells in vitro: the key to rational vaccine design. Annu. Rev. Immunol. 23: 651-682.
42. Smyth, L. A., O. B. Herrera, D. Golshayan, G. Lombardi, and R. I. Lechler. 2006. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation 82: S15-S18.
43. Carbone, F. R., G. T. Belz, and W. R. Heath. 2004. Transfer of antigen between migrating and lymph node resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol. 25: 654-658.
44. + T cells after viral stimulation. PLoS ONE 3: 1-10.
45. Harshyne, L. A., S. C. Watkins, A. Gambotto, and S. M. Barratt-Boyes. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166: 3717-3723.
46. Harshyne, L. A., M. I. Zimmer, S. C. Watkins, and S. M. Barratt-Boyes. 2003. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol. 170: 2302-2309.
47. Morelli, A. E., A. T. Larregina, W. J. Shufesky, M. L. Sullivan, D. B. Stolz, G. D. Papworth, A. F. Zahorchak, A. J. Logar, Z. Wang, S. C. Watkins, et al. 2004. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104: 3257-3266.
48. + dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J. Immunol. 179: 1489-1496.
49. Kurts, C., W. Heath, F. Carbone, J. Allison, J. Miller, and H. Kosaks. 1996. Constitutive Class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184: 923-930. (Pubitemid 26313550)